Pricing scales with your dose. See full pricing by dose →
Tirzepatide is the active ingredient in branded medications like Mounjaro and Zepbound. Unlike semaglutide, it activates both the GLP-1 and GIP receptors, which produces stronger appetite suppression and metabolic effects in head-to-head trials. Patients typically see faster initial loss and a higher ceiling at maintenance dose.
Subcutaneous injection one time per week using a single-use syringe. Self-administered at home after a short tutorial during your initial consult.
All patients start at 2.5 mg weekly for the first 4 weeks. Titration increases happen in 4 to 8 week intervals based on response.
Most patients land at 5 mg, 7.5 mg, 10 mg, or 12.5 mg weekly. Our NP will guide you to the right dose for your goals.
Telehealth removes the parts of traditional wellness care that waste your time. Here's how the journey starts.
Pricing scales with your dose so titration costs are predictable. Most patients live at 5 mg or 7.5 mg per week.
Your initial consult is free. Monthly subscription includes medication, sterile supplies, and ongoing clinical access. A flat $25 monthly shipping fee is added to cover delivery.
Tirzepatide tends to produce the strongest results in patients with 30+ pounds to lose, type 2 diabetes, or a prior plateau on semaglutide. Our NP helps you decide if tirzepatide or semaglutide is the better starting point.
Tirzepatide is the active ingredient in well-known branded medications like Mounjaro and Zepbound. The version we prescribe is compounded by a California-licensed 503A pharmacy specifically for you based on your clinical visit. Compounded medications are not separately approved by the FDA as finished pharmaceutical products. They are legal under federal and California law when prescribed for a specific patient based on a clinical evaluation.
Tirzepatide is more potent than semaglutide and tends to produce more pronounced gastrointestinal side effects during titration. Our NP starts every patient at 2.5 mg weekly and moves the dose up slowly so your body has time to adapt. Individual results vary, and the best outcomes happen when the medication is paired with sleep, protein, and movement.
Book a free video consult and start your Semaglutide program. Our NP reviews every new patient personally.
Or call us at [Phone Number]
Tirzepatide activates both GLP-1 and GIP receptors; semaglutide only activates GLP-1. In head-to-head trials, tirzepatide shows roughly 20 percent average weight loss at 15 mg weekly versus 15 percent for semaglutide at 2.4 mg weekly. Tirzepatide tends to suppress appetite more strongly but also produces more pronounced GI side effects during titration.
The active ingredient is the same. The branded products are FDA-approved finished pharmaceuticals manufactured by Eli Lilly. The compounded tirzepatide we prescribe is prepared by a California-licensed 503A pharmacy for you specifically. Compounded medications are not separately approved by the FDA as finished pharmaceutical products. They are legal under federal and California law when prescribed for a specific patient based on a clinical visit.
Yes. The initial 30 to 45 minute video consult with our NP is free. You only pay if you decide to start the program. There’s no obligation and no pressure if it turns out this service isn’t right for you.
No. Pause and Power Health is a telehealth program licensed in California. Patients can be located anywhere in the state, from San Diego to the Bay Area. Your video visit happens wherever you have a private space and an internet connection, and your medication ships to your home.
After your consult, our NP sends the prescription to a California-licensed pharmacy. The pharmacy ships your monthly supply directly to your home with everything you need. A flat $25 monthly shipping fee covers delivery.
Pause and Power Health is a cash-pay practice. We don’t bill insurance directly. On request, we can provide an itemized superbill that you may submit for possible out-of-network reimbursement. Most patients use HSA or FSA funds toward consultations and medications.